Block.One's investment branch, both the EOS VC Grants program and the FinLab EOS VC, are focusing more on companies that create blockchain solutions addressing the COVID-19, highlighting the potential and benefits of the EOSIO software.
Their latest investments and grants include:
"The use of blockchain, big data analytics, new technologies and proactive testing all play a central role in ensuring that the work of many labs and organizations around the globe can come together to respond to COVID-19 with the speed and agility required to help governments flatten not only the curve but the disease. The integration of EOSIO in our platform ensures that we can rapidly aggregate unpublished data that currently sits in silos around the world to speed actionable insights across the drug development life cycle for the development of tests and treatments for COVID-19." - Gunjan Bhardwaj, CEO of Innoplexus AG.